9th Feb, 2018 at AIIMS, New Delhi

“Pre-Consultative Meeting with government stakeholder agencies was held at AIIMS on 9th February 2018” to seek further inputs on the “Guidelines for Evaluation of Nanopharmaceuticals in India” and discuss strategies for Indo-US Symposium on Nanobiotechnology Regulatory Science. Key stakeholder government agencies such as DST, DBT, ICMR, ICAR, DCGI, CIB and FSSAI along with academic were brought on a common platform to discuss the draft guidelines and issues related to promoting nanotechnology regulatory research in India in engagement with USFDA.